IOL Chemicals and Pharmaceuticals Reports Q1 Results for June 2026; Revenue stands at 756.26 Crore
IOL Chemicals and Pharmaceuticals Limited released its Standalone and Consolidated Unaudited Financial Results for the quarter ending June 30, 2026. The company reported a Total Income of 764.44 crore, with a Profit for the period standing at 64.40 crore, according to the unaudited results.The consolidated results showed significant operations across its business segments in both pharmaceuticals and chemicals. For the quarter ended June 30, 2026, the total net sales/income from operations stood at 764.44 crore. The company generated a Total Income of 764.44 crore (comprising Revenue from Operations of 756.26 and Other Income of 8.18).
Financial analysis highlighted key metrics for the quarter, which is presented below:
| Financial Metric | Q ended June 30, 2026 (₹ Crore) | Q ended March 31, 2026 (₹ Crore) | Q ended June 30, 2025 (₹ Crore) | Year ended March 31, 2026 (₹ Crore) |
|---|---|---|---|---|
| Total Income | 764.44 | 621.29 | 559.06 | 2,340.44 |
| Total Expenses | 677.75 | 550.48 | 513.55 | 2,144.87 |
| Profit before Tax | 86.69 | 70.81 | 45.51 | 195.57 |
| Total Tax Expense | 22.29 | 17.65 | 11.58 | 46.72 |
| Profit for the Period | 64.40 | 53.16 | 33.93 | 137.64 |
The company's segment-wise results reflect robust performance in both core business areas. Total Net Sales/Income from Operations totaled 764.44 crore for the quarter ended June 30, 2026. This was generated by its two primary segments: Pharmaceutical and Chemical.
The segmented revenue breakdown is as follows:
| Segment | Net Sales/Income from Operations (₹ Crore) |
|---|---|
| Pharmaceutical | 469.49 |
| Chemical | 364.96 |
| Unallocated | 8.18 |
| Total | 764.44 |
In terms of segment results, the total Profit before Tax and Extraordinary items for the quarter ended June 30, 2026, was 86.69 crore. The Pharmaceutical segment contributed 68.81 crore to this profit, while the Chemical segment reported a profit of 17.32 crore.
The results show consistency in the company's financial structure across periods, with revenue and profitability figures consistently presented for both the latest quarter and prior comparable quarters. Management also provided data on segment assets and liabilities as part of the unaudited results.
IOLCP Stock Price Movement
IOL Chemicals and Pharmaceuticals stock surges toward its yearly high, edging higher to ₹177.24 as live trading stands at 2:45 PM. The company’s equity continues strong movement after the shares traded robustly within a tight intraday range ranging from ₹167.7 to ₹178.79, with 5.46 million shares already transacted.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.